Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Fuji
Fish and Richardson
Cipla
Julphar
Dow
Teva
Cerilliant
Johnson and Johnson
Daiichi Sankyo

Generated: October 23, 2017

DrugPatentWatch Database Preview

Liebel-flarsheim Company Profile

« Back to Dashboard

What is the competitive landscape for LIEBEL-FLARSHEIM, and what generic and branded alternatives to LIEBEL-FLARSHEIM drugs are available?

LIEBEL-FLARSHEIM has eleven approved drugs.



Summary for Applicant: Liebel-flarsheim

US Patents:0
Tradenames:14
Ingredients:5
NDAs:11
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Liebel-flarsheim
CONRAY 30
iothalamate meglumine
INJECTABLE;INJECTION016983-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Liebel-flarsheim
CONRAY
iothalamate meglumine
INJECTABLE;INJECTION013295-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Liebel-flarsheim
OPTIRAY 300
ioversol
INJECTABLE;INJECTION020923-004May 13, 1999RXYesYes► Subscribe► Subscribe► Subscribe
Liebel-flarsheim
OPTIRAY 300
ioversol
INJECTABLE;INJECTION019710-004Jan 22, 1992RXYesYes► Subscribe► Subscribe► Subscribe
Liebel-flarsheim
OPTIMARK IN PLASTIC CONTAINER
gadoversetamide
INJECTABLE;INJECTION020976-001Dec 8, 1999RXYesYes► Subscribe► Subscribe► Subscribe
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020937-002Dec 8, 1999RXYesYes► Subscribe► Subscribe► Subscribe
Liebel-flarsheim
OPTIRAY 320
ioversol
INJECTABLE;INJECTION020923-002May 29, 1998RXYesYes► Subscribe► Subscribe► Subscribe
Liebel-flarsheim
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
sodium chloride
INJECTABLE;INJECTION021569-001Jul 27, 2006RXYesYes► Subscribe► Subscribe► Subscribe
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020975-001Dec 8, 1999RXYesYes► Subscribe► Subscribe► Subscribe
Liebel-flarsheim
MD-76R
diatrizoate meglumine; diatrizoate sodium
INJECTABLE;INJECTION019292-001Sep 29, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Liebel-flarsheim

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Liebel-flarsheim
OPTIMARK IN PLASTIC CONTAINER
gadoversetamide
INJECTABLE;INJECTION020976-001Dec 8, 1999► Subscribe► Subscribe
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020975-001Dec 8, 1999► Subscribe► Subscribe
Liebel-flarsheim
OPTIRAY 160
ioversol
INJECTABLE;INJECTION019710-003Dec 30, 1988► Subscribe► Subscribe
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020937-001Dec 8, 1999► Subscribe► Subscribe
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020975-001Dec 8, 1999► Subscribe► Subscribe
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020937-003Dec 8, 1999► Subscribe► Subscribe
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020937-004Dec 8, 1999► Subscribe► Subscribe
Liebel-flarsheim
OPTIMARK IN PLASTIC CONTAINER
gadoversetamide
INJECTABLE;INJECTION020976-001Dec 8, 1999► Subscribe► Subscribe
Liebel-flarsheim
OPTIRAY 320
ioversol
INJECTABLE;INJECTION020923-002May 29, 1998► Subscribe► Subscribe
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020937-004Dec 8, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Novartis
Covington
Farmers Insurance
Express Scripts
US Department of Justice
Fuji
McKesson
Federal Trade Commission
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot